1. Home
  2. R vs SYRE Comparison

R vs SYRE Comparison

Compare R & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ryder System Inc.

R

Ryder System Inc.

HOLD

Current Price

$243.68

Market Cap

6.5B

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$73.58

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
R
SYRE
Founded
1933
2013
Country
United States
United States
Employees
N/A
112
Industry
Rental/Leasing Companies
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
6.5B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
R
SYRE
Price
$243.68
$73.58
Analyst Decision
Buy
Strong Buy
Analyst Count
10
12
Target Price
$238.56
$85.08
AVG Volume (30 Days)
381.6K
927.8K
Earning Date
04-23-2026
05-08-2026
Dividend Yield
1.48%
N/A
EPS Growth
7.96
N/A
EPS
2.33
N/A
Revenue
$12,665,000,000.00
N/A
Revenue This Year
$5.00
N/A
Revenue Next Year
$5.05
N/A
P/E Ratio
$102.36
N/A
Revenue Growth
0.23
N/A
52 Week Low
$143.34
$13.93
52 Week High
$259.00
$78.80

Technical Indicators

Market Signals
Indicator
R
SYRE
Relative Strength Index (RSI) 60.00 57.09
Support Level $184.78 $67.18
Resistance Level $259.00 $76.16
Average True Range (ATR) 6.97 4.12
MACD -0.66 -0.97
Stochastic Oscillator 86.34 62.77

Price Performance

Historical Comparison
R
SYRE

About R Ryder System Inc.

Ryder System Inc operates in three business segments: (1) Fleet Management Solutions which provides full-service leasing and leasing with flexible maintenance options, commercial rental and maintenance services of trucks, tractors and trailers to customers; (2) Supply Chain Solutions (SCS), which provides integrated logistics solutions, including distribution management, dedicated transportation, transportation management, brokerage, e-commerce, last mile, and professional services; and (3) Dedicated Transportation Solutions (DTS), which provides turnkey transportation solutions in the U.S., including dedicated vehicles, professional drivers, management, and administrative support.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: